Quantcast
Last updated on April 20, 2014 at 8:28 EDT

2013 Deep Research Report on China Human Use Rabies Vaccine Industry

November 13, 2013

DUBLIN, November 13, 2013 /PRNewswire/ –

Research and Markets ( http://www.researchandmarkets.com/research/tmp22h/2013_deep
) has announced the addition of the “2013 Deep Research Report on China Human Use Rabies
Vaccine Industry” [http://www.researchandmarkets.com/research/tmp22h/2013_deep ] report to
their offering.

(Logo:
http://photos.prnewswire.com/prnh/20130307/600769 )

This 2013 Deep Research Report is a professional and in-depth research report on the
Chinese Human Use Rabies Vaccine industry. In the beginning the report describes the
definition, classification, industry chain and other related information of the industry.
It then discusses manufacturing technology and product specifications.

This report gives summary statistics on Chinas major Rabies Vaccine manufacturers
giving details on capacity, production, supply, demand, shortage, selling price, cost,
gross margin, production value and Chinese market share.

In the end, this report discusses the 4 Million Boxes/year Human Use Rabies Vaccine
[http://www.researchandmarkets.com/research/tmp22h/2013_deep ] project feasibility
analysis and investment return analysis and gives related research conclusions and
development trend analysis of the industry.

Key Topics Covered:

Chapter One Human Use Rabie Vaccine (Hamster Kidney Cell) Industry Overview

Chapter Two Human Use Rabie Vaccine (Vero Cell) Industry Overview

Chapter Three Human Use Rabie Vaccine (Chicken Embryo Cell) Industry Overview

Chapter Four Human Use Rabie Vaccine Industry Chain Analysis

Chapter Five Human Use Rabie Vaccine Production Supply Sales Demand Market Status and
Forecast

Chapter Six Human Use Rabie Vaccine Key Manufacturer Analysis

Chapter Seven Human Use Rabie Vaccine New Project Investment Feasibility Analysis

Chapter Eight Human Use Rabie Vaccine Industry Research Conclusions

Companies Mentioned

– Yatai Group
- Dalian Hissen
- Langzhou Institute of Biological Products
- Henan Puxin Biological Engineering (2011 Sold To Yatai Group)
- ForwellBoipharm (2010 Stop)
- ChengdaBoitechnology
- Liaoning Yisheng
- Promise Biological
- BCHT Pharm (Jilin Maifeng)
- Changchun Changsheng
- Zhejiang Vacinbio-pharmaceutical
- Wuhan Institute of Biological Products (2011 Stop)
- Jiangsu Yansheng Biological (2010 Stop)
- Dalian JingangAndi Biological (2009 Stop)
- Sanofipasteur
- Chiron Behring

For more information visit

http://www.researchandmarkets.com/research/tmp22h/2013_deep

        Research and Markets
        Laura Wood, Senior Manager.
        press@researchandmarkets.com
        U.S. Fax: +1-646-607-1907
        Fax (outside U.S.): +353-1-481-1716
        Sector: Pharmaceuticals
         [http://www.researchandmarkets.com/categories.asp?cat_id=16&campaign_id=tmp22h ]


    Photo: 

http://photos.prnewswire.com/prnh/20130307/600769

SOURCE Research and Markets


Source: PR Newswire